Abnormal Lung Sounds in Congestive Heart Failure

Clinical Presentation

The European Society of Cardiology recommends that pulmonary rales (crackles) are the hallmark lung sounds in congestive heart failure (CHF) and indicate pulmonary congestion requiring prompt treatment with diuretics, vasodilators, and addressing the underlying cardiac dysfunction 1
Rales (crackles) are the predominant abnormal lung sound in CHF, typically heard at the lung bases first and may extend throughout both lung fields as severity increases, according to the American College of Cardiology and European Heart Journal 1, 2
The presence of rales helps classify heart failure severity according to the Killip classification, which includes four classes, as stated by the European Heart Journal 1

Management

The European Heart Journal recommends that oxygen therapy should be administered immediately to improve oxygenation, and intravenous loop diuretics (e.g., furosemide) should be given promptly to reduce pulmonary congestion 1, 3
The American College of Cardiology suggests that vasodilators, particularly intravenous nitroglycerin, should be administered unless the patient is hypotensive (systolic BP <90 mmHg), as recommended by the European Heart Journal 1
Loop diuretics are the cornerstone for treating pulmonary congestion, with dosing titrated to resolve clinical evidence of congestion, according to Anaesthesia 3
Serial lung examinations should be performed to assess resolution of rales, as recommended by the European Heart Journal and Journal of the American College of Cardiology 1, 2
Natriuretic peptides (BNP or NT-proBNP) should be monitored, with a decrease >30% by day 5 and discharge value <1500 pg/mL indicating good prognosis, as stated by Anaesthesia 3

Special Considerations

Not all CHF patients present with classic pulmonary rales - some may have predominantly peripheral edema with minimal lung findings, according to Circulation and Journal of the American College of Cardiology 4, 2
The absence of rales does not rule out heart failure, as patients may have exercise intolerance without evidence of fluid retention, as recommended by Circulation and Journal of the American College of Cardiology 4, 2

Pulmonary Edema in Congestive Heart Failure

Pathophysiology and Clinical Presentations

The European Society of Cardiology notes that in congestive heart failure (CHF), cardiac dysfunction results in inadequate forward flow and increased backward pressure, leading to pulmonary congestion 5, 6
Acute pulmonary edema presents with severe respiratory distress, tachypnea, orthopnea, and rales over the lung fields, according to the European Heart Journal 5
Arterial oxygen saturation is typically less than 90% on room air prior to treatment with oxygen, as reported by the European Heart Journal 5
Major clinical signs include orthopnea, jugular venous distension, hepatojugular reflux, rales, S3 gallop rhythm, and cardiomegaly, as outlined by the American College of Cardiology 7

Types of Heart Failure and Management

Both heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF) can cause pulmonary edema, according to the American College of Cardiology and the European Heart Journal 8, 9
Hypertensive heart failure often presents with pulmonary congestion without significant peripheral edema, as noted by the European Heart Journal 5
Vasodilators like nitroglycerin are effective first-line treatments for reducing preload and improving symptoms, as recommended by the American College of Cardiology 10

Risk Factors and Monitoring

History of previous heart failure, prior myocardial infarction, symptomatic coronary artery disease, hypertension, left ventricular hypertrophy, advanced age, long-standing diabetes, preexisting edema, and chronic renal failure are risk factors for pulmonary edema, as identified by the American Heart Association 11
Patients with heart failure should be instructed to monitor for weight gain and the presence of pedal edema, and symptoms suggestive of developing pulmonary edema include orthopnea, paroxysmal nocturnal dyspnea, unexplained cough or fatigue, as advised by the American Heart Association 11
Echocardiography is essential to assess cardiac function and identify structural abnormalities contributing to pulmonary edema, as recommended by the American College of Cardiology 7

Pulmonary Findings in Congestive Heart Failure

Key Radiographic and Histologic Findings

The European Heart Journal recommends that chest X-ray in congestive heart failure demonstrates pulmonary venous congestion, interstitial edema, pleural effusions, and Kerley B lines, all resulting from elevated left ventricular filling pressures that cause fluid to accumulate in the pulmonary interstitium and alveolar spaces 12, 13, 14, 15
Pulmonary venous congestion represents redistribution of blood flow to upper lung zones due to elevated left ventricular filling pressure, and confirms left heart failure when present on chest radiograph 12, 13, 14, 15
Interstitial edema is caused by elevated left ventricular filling pressure exceeding oncotic pressure, forcing fluid across the alveolar-capillary membrane, and appears as hazy, indistinct vascular markings on chest X-ray 12, 13, 14, 15
Kerley B lines indicate increased lymphatic pressures from chronic fluid accumulation, and are particularly associated with mitral stenosis or chronic heart failure 12, 13, 14, 15
Pleural effusions result from elevated filling pressures, and represent transudation of fluid into pleural space from elevated hydrostatic pressure 12, 13, 14, 15
Cardiomegaly is characterized by an enlarged cardiac silhouette from dilated left ventricle, right ventricle, or atria, and may be absent in acute heart failure or even chronic cases 12, 13, 14, 15

Clinical Severity Classification

The European Heart Journal describes the Killip Classification, which includes four classes:

Important Clinical Caveats

A normal chest X-ray makes pulmonary congestion unlikely, but does not completely rule out heart failure, especially in early or well-compensated cases 12, 13, 14, 15
Diagnostic confirmation requires echocardiography to assess systolic and diastolic function, as chest X-ray findings alone have limited predictive value without clinical context 12, 13, 14, 15

Kerley Lines in Heart Failure Diagnosis and Management

Diagnostic Approach

The European Society of Cardiology recommends measuring plasma natriuretic peptides (BNP, NT-proBNP, or MR-proANP) using point-of-care assay to differentiate acute heart failure from non-cardiac causes of dyspnea 16
Bedside lung ultrasound should be performed if expertise is available, as it has superior sensitivity compared to chest X-ray for detecting interstitial syndrome 17, 18
An ECG should be obtained to exclude ST-elevation myocardial infarction, and laboratory assessment should include troponin, BUN/urea, creatinine, electrolytes, glucose, and complete blood count 16

Monitoring Response to Therapy

Serial lung examinations and lung ultrasound quantification of B-lines provide an objective assessment of treatment response 17, 18
B-line quantification on ultrasound is directly proportional to the severity of pulmonary congestion 17, 18
Decreasing the number of B-lines on serial ultrasound indicates successful diuresis 18, 19

Ultrasound Superiority Over Chest X-Ray

Lung ultrasound should be used as the first-line diagnostic approach for suspected interstitial syndrome, as it has superior sensitivity compared to conventional chest X-ray and may lead to better patient outcomes 17, 18
Chest X-ray is normal in nearly 20% of acute heart failure patients, limiting its sensitivity 16
Lung ultrasound allows direct visualization of interstitial edema with higher sensitivity 17, 16

Acute Management of Cardiomegaly with Mild Cardiogenic Pulmonary Edema

Immediate Stabilization Measures

Supplemental oxygen should be administered immediately to correct hypoxemia and improve tissue oxygenation in patients presenting with acute pulmonary congestion. 20
Target oxygen saturation ≥ 90 %; patients often present with saturations < 90 % on room air before therapy. 21
Non‑invasive positive‑pressure ventilation (CPAP or BiPAP) is recommended for patients with severe respiratory distress that does not rapidly improve with oxygen and diuretics. 20
Endotracheal intubation and mechanical ventilation are reserved for those with refractory hypoxia or respiratory acidosis despite less invasive measures. 22

Pharmacologic Interventions

Vasodilators (First‑Line)

Sublingual nitroglycerin 0.4–0.6 mg, repeat every 5–10 min up to four doses, is effective for both ischemic and non‑ischemic causes of acute pulmonary edema. 22
If systolic blood pressure ≥ 95–100 mmHg, initiate intravenous nitroglycerin at 0.3–0.5 µg·kg⁻¹·min⁻¹ and titrate upward to improve clinical status. [20][22]
Vasodilators reduce preload and afterload, thereby decreasing pulmonary congestion without the need for immediate diuresis. [20][22]

Loop Diuretics

Furosemide 20–80 mg IV should be given shortly after confirming the diagnosis of pulmonary edema. 22

Morphine Sulfate (Selective Use)

Morphine 3–5 mg IV may be considered to alleviate anxiety and dyspnea in acute pulmonary edema, provided the patient does not have chronic pulmonary insufficiency, respiratory acidosis, or metabolic acidosis. 22

Diagnostic Workup During Stabilization

Laboratory panel (CBC, electrolytes, renal function, troponin, glucose, thyroid function) should be obtained promptly to guide therapy and identify comorbidities. 23
12‑lead ECG must be performed immediately to rule out ST‑elevation myocardial infarction, detect arrhythmias, and assess conduction abnormalities. 23
Natriuretic peptide measurement (BNP or NT‑proBNP) assists in confirming heart‑failure etiology and provides a baseline for monitoring response. 23
Transthoracic echocardiography is mandatory during the initial evaluation to determine left‑ventricular ejection fraction, chamber dimensions, wall thickness, valve function, and structural abnormalities. 23

Severity Assessment & Phenotype Classification

The presentation reflects left‑heart backward failure of mild‑to‑moderate severity, characterized by pulmonary congestion without frank alveolar edema or cardiogenic shock. [20][21]
According to the European Society of Cardiology (ESC), this condition is classified as Acute Decompensated Heart Failure (ADHF) or Hypertensive ADHF when blood pressure is elevated. 21

Monitoring Response to Treatment

Clinical improvement should be tracked by serial assessment of dyspnea, orthopnea, and oxygen saturation. 20
Urine output is a key indicator of diuretic efficacy; aim for > 0.5 mL·kg⁻¹·h⁻¹. 21
Electrolyte re‑checking (especially potassium and magnesium) after diuresis is essential to prevent arrhythmias. 23

Addressing Underlying Etiology

Acute coronary syndrome requires urgent coronary angiography and revascularization when indicated. [20][23]
Severe hypertension should be aggressively managed with vasodilators; if nitroglycerin is insufficient, consider sodium nitroprusside starting at 0.1 µg·kg⁻¹·min⁻¹. [20][22]
Acute valvular dysfunction (e.g., mitral or aortic regurgitation) may necessitate prompt surgical consultation. [20][21]
Arrhythmias (e.g., rapid atrial fibrillation, ventricular tachycardia) demand immediate rate or rhythm control. 21
Non‑cardiovascular precipitants such as medication non‑adherence, volume overload, infection, renal impairment, or anemia should be identified and treated. 21

Initiation of Long‑Term Guideline‑Directed Medical Therapy

After stabilization, initiate or optimize guideline‑directed therapy for heart failure with reduced ejection fraction (ACE‑inhibitors/ARBs, beta‑blockers, aldosterone antagonists). [20][23]
Correct underlying anatomical lesions when feasible to reduce the risk of recurrent acute decompensation. 20

Critical Pitfalls to Avoid

Do not use vasodilators when systolic blood pressure < 90 mmHg, as this may precipitate cardiogenic shock. [20][22]
In cardiogenic shock (SBP < 90 mmHg, cardiac index < 2.2 L·min⁻¹·m⁻², signs of hypoperfusion), vasodilators and diuretics are contraindicated; inotropic support and possibly mechanical circulatory support are required. 21
Avoid assuming all pulmonary edema is cardiogenic; exclude non‑cardiogenic causes (e.g., ARDS, sepsis, neurogenic edema) through clinical context and appropriate testing. 22
Failure to obtain early echocardiography delays definitive diagnosis and identification of structural abnormalities needing specific interventions. 23
Inadequate electrolyte monitoring during diuresis can lead to life‑threatening arrhythmias. 23